BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 20346624)

  • 41. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    J Clin Epidemiol; 2006 Nov; 59(11):1134-49. PubMed ID: 17027423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    J Clin Epidemiol; 2016 May; 73():142-52. PubMed ID: 27101888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Consolidated Standards of Reporting Trials (CONSORT): Guidelines for reporting randomized trials.
    Bennett JA
    Nurs Res; 2005; 54(2):128-32. PubMed ID: 15778654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
    Vandenbroucke JP; von Elm E; Altman DG; Gøtzsche PC; Mulrow CD; Pocock SJ; Poole C; Schlesselman JJ; Egger M;
    Int J Surg; 2014 Dec; 12(12):1500-24. PubMed ID: 25046751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Have CONSORT guidelines improved the quality of reporting of randomised controlled trials published in public health dentistry journals?
    Savithra P; Nagesh LS
    Oral Health Prev Dent; 2013; 11(2):95-103. PubMed ID: 23534035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
    Piaggio G; Elbourne DR; Pocock SJ; Evans SJ; Altman DG;
    JAMA; 2012 Dec; 308(24):2594-604. PubMed ID: 23268518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guidelines for reporting randomized controlled trials in paediatric dentistry based on the CONSORT statement.
    Jayaraman J
    Int J Paediatr Dent; 2020 Dec; 31 Suppl 1():38-55. PubMed ID: 32976673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.
    Moher D; Jones A; Lepage L;
    JAMA; 2001 Apr; 285(15):1992-5. PubMed ID: 11308436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of instructions for authors and published papers.
    Li XQ; Tao KM; Zhou QH; Moher D; Chen HY; Wang FZ; Ling CQ
    PLoS One; 2012; 7(2):e30683. PubMed ID: 22348017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
    Junqueira DR; Zorzela L; Golder S; Loke Y; Gagnier JJ; Julious SA; Li T; Mayo-Wilson E; Pham B; Phillips R; Santaguida P; Scherer RW; Gøtzsche PC; Moher D; Ioannidis JPA; Vohra S;
    J Clin Epidemiol; 2023 Jun; 158():149-165. PubMed ID: 37100738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protocol for CONSORT-SPI: an extension for social and psychological interventions.
    Montgomery P; Grant S; Hopewell S; Macdonald G; Moher D; Michie S; Mayo-Wilson E
    Implement Sci; 2013 Sep; 8():99. PubMed ID: 24004579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A standard method for reporting ramdomized medical scientific research; the 'Consolidation of the standards of reporting trials' (CONSORT)].
    Ned Tijdschr Geneeskd; 1998 May; 142(19):1089-91. PubMed ID: 9623225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers.
    Moher D; Hopewell S; Schulz KF; Altman DG
    Trials; 2011 Apr; 12():98. PubMed ID: 21504615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement.
    Mills EJ; Wu P; Gagnier J; Devereaux PJ
    Contemp Clin Trials; 2005 Aug; 26(4):480-7. PubMed ID: 16054580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.